KPV treatment guide

Word briefing · FDA approval

Approval is about a specific medicine.

FDA, the Food and Drug Administration, reviews each particular medicine for a specified medical use.

Where KPV stands

No KPV medicine had been approved by FDA for any medical use in the United States as of September 28, 2026.

A reference to KPV in an FDA document does not mean FDA has approved a treatment.

A code is not the review

NDC stands for National Drug Code and identifies a product in FDA’s listing.

As of September 26, 2026, FDA’s guidance says that directory entry does not show that a product has FDA approval.

Under FDA’s rule checked on September 26, 2026, recording a business or product with the agency does not mean the product is approved.

Read an approval claim closely. Which finished medicine and which use does it refer to?

Compounding has a separate meaning

Compounding is making a medicine to order, in place of supplying a drug maker’s finished product.

FDA does not assess a compounded medicine’s safety, benefit or quality before it is offered, as of September 26, 2026.

Ask for the basis of a treatment claim rather than accepting a directory code as the answer.

Chapter notes

Approval finding

FDA application records for KPV were checked on September 28, 2026.

Open the FDA application records

Directory codes

FDA explains what a directory entry can and cannot establish.

Read the drug-code explanation

Registration

The federal registration rule separates listing from approval.

Read the registration rule